Physician profile
James A Posey
NPI 1427082734
$8,034.49
in general payments reported to CMS, 2019-2025
14 companies · $26.55 in 2025
The $26.55 reported for 2025 was less than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151 · 2020: $1,518 · 2022: $192 · 2023: $6,146 · 2025: $26.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,395 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,395.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Food and Beverage | $277.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $3,000.00 | 2020-2023 | |
| Seagen INC. | $2,520.00 | 2023 | |
| Eli Lilly and Company | $1,875.00 | 2023 | |
| Angiodynamics, INC. | $192.37 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $189.22 | 2023 | Onivyde, Somatuline Depot |
| Allergan, INC. | $157.21 | 2019-2020 | |
| Abbvie INC. | $88.76 | 2023-2025 | |
| Foundation Medicine, INC. | $11.93 | 2019 |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Posey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.